510(k) · Cleared
ClearedTraxcess 0.014 Hydrophilic Guidewire
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
MicroVention, Inc. · DQX Wire, Guide, Catheter
Cleared on Apr 17, 2008 as substantially equivalent to K063695 (Terumo Medical Corp., 2007) and 2 other predicates after a 20-day review. Its family tree reaches back 3 generations to 1995. 12 later devices descend from it.
- Decided
- Apr 17, 2008
- Review
- 20 days
- Class
- Class II
- Product code
- DQX
- Recalls
- None
- Predicates
- 3
Its longest line of descent runs back 3 generations to K953533 (1995). 5 ancestors in all. 12 later devices descend from it, 2 citing it directly.
- Root · 3 generations backK953533 Radifocus Glidewire for Coronary Use with Platinum (or Gold) CoilTerumo Medical Corp. · 1995
- 2 generations backK961445 Radifocus Glidewire for Coronary Use with Platinum (or Gold) CoilTerumo Medical Corp. · 1996
- 1 generation backK063695 Runthrough NSTerumo Medical Corp. · 2007 · Recalled
- This deviceK080863 Traxcess 0.014 Hydrophilic GuidewireMicroVention, Inc. · 2008
- Descendant · cites it directly · 9 of its ownK133725 Traxcess 14 GuidewireMicroVention, Inc. · 2014
- Descendant · 2 generations on · 4 of its ownK153053 Traxcess Pro 14 GuidewireMicroVention, Inc. · 2015
- Descendant · 3 generations on · 2 of its ownK161803 Traxcess .007 Mini GuidewireMicroVention, Inc. · 2016 · Recalled
- Descendant · 2 generations on · 1 of its ownK182337 HYBRID GuidewireBalt USA, LLC · 2018
- Descendant · cites it directly · 1 of its ownK093397 Traxcess 14EX Guidewire and Traxcess Docking WireMicroVention, Inc. · 2009
Showing 5 of 12 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 12 · See all- K133725Traxcess 14 GuidewireMicroVention, Inc. · 2014 · cites it directly9descendants
- K153053Traxcess Pro 14 GuidewireMicroVention, Inc. · 2015 · 2 generations on4descendants
- K161803Traxcess .007 Mini GuidewireMicroVention, Inc. · 2016 · 3 generations on2descendants
- K182337HYBRID GuidewireBalt USA, LLC · 2018 · 2 generations on1descendant
- K093397Traxcess 14EX Guidewire and Traxcess Docking WireMicroVention, Inc. · 2009 · cites it directly1descendant
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K953533 | Radifocus Glidewire for Coronary Use with Platinum (or Gold) Coil | Terumo Medical Corp. | 1995 | — |
| −2 | K961445 | Radifocus Glidewire for Coronary Use with Platinum (or Gold) Coil | Terumo Medical Corp. | 1996 | — |
| −1 | K063695 | Runthrough NS | Terumo Medical Corp. | 2007 | 1 |
| 0 (this device) | K080863 | Traxcess 0.014 Hydrophilic Guidewire | MicroVention, Inc. | 2008 | — |
| +1 | K133725 | Traxcess 14 Guidewire | MicroVention, Inc. | 2014 | — |
| +2 | K153053 | Traxcess Pro 14 Guidewire | MicroVention, Inc. | 2015 | — |
| +3 | K161803 | Traxcess .007 Mini Guidewire | MicroVention, Inc. | 2016 | 1 |
| +2 | K182337 | HYBRID Guidewire | Balt USA, LLC | 2018 | — |
| +1 | K093397 | Traxcess 14EX Guidewire and Traxcess Docking Wire | MicroVention, Inc. | 2009 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2009 | 1 | 0 |
| 2014 | 1 | 0 |
| 2015 | 1 | 0 |
| 2016 | 2 | 0 |
| 2018 | 1 | 0 |
| 2019 | 1 | 0 |
| 2020 | 3 | 0 |
| 2026 | 2 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in DQX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new DQX device
- #1 K213854 SavvyWirescore 15.7 · 10 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (3)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K063695 | Runthrough NSSummary page 1…y: MicroVention, Inc. 75 Columbia, Suite A Aliso Viejo, CA 92656 Contact: Kevin E. Daly Predicate Runthrough NS (K063695) Devices: Transend EX Platinum Guidewire (K971254) Radifocus Glidewire GT with Gold Coil (K955801) De… | 2007 |
| * | K971254 | Transend EX Platinum GuidewireSummary page 1…ite A Aliso Viejo, CA 92656 Contact: Kevin E. Daly Predicate Runthrough NS (K063695) Devices: Transend EX Platinum Guidewire (K971254) Radifocus Glidewire GT with Gold Coil (K955801) Device Description: The Traxcess 0.014" Hydrophilic Guidewire… | 1997 |
| * | K955801 | Radifocus Glidewire GT with Gold Coil,Glidewire GoldSummary page 1…vin E. Daly Predicate Runthrough NS (K063695) Devices: Transend EX Platinum Guidewire (K971254) Radifocus Glidewire GT with Gold Coil (K955801) Device Description: The Traxcess 0.014" Hydrophilic Guidewire consists of a 0.014" stainless steel shaft and a tapered nitinol… | 1996 |
What descends from it? (12)
See all 122 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 13 years and passes through 2 companies; a new generation was cleared every 12 months on median.
- 1 of the 5 ancestors has a recall of any class.
- Of its descendants, K133725 (MicroVention, Inc., 2014) has gone furthest, with 9 descendants of its own.
- 2 other devices also cite its predicate K063695.
How does its category compare?
All DQX devicesDQX Wire, Guide, Catheter: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.
FDA decisions per year · DQX
10in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · DQX
177in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · DQX
3in 2024
Class I (8 since 2007) Class II/III not classified
Adverse event reports per year · DQX
2,178in 2025
MAUDE reports naming product code DQX, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 14 | 85 | 12 | 760 |
| 2008 | 19 | 87 | 7 | 715 |
| 2009 | 18 | 87 | 49 | 687 |
| 2010 | 21 | 63 | 34 | 987 |
| 2011 | 18 | 43 | 3 | 1,311 |
| 2012 | 20 | 62 | 5 | 1,337 |
| 2013 | 18 | 119 | 7 (4) | 1,474 |
| 2014 | 18 | 103 | 0 | 1,323 |
| 2015 | 15 | 112 | 1 | 1,323 |
| 2016 | 14 | 179 | 2 (2) | 1,466 |
| 2017 | 19 | 85 | 17 | 1,524 |
| 2018 | 19 | 114 | 9 | 1,737 |
| 2019 | 13 | 173 | 2 | 1,679 |
| 2020 | 14 | 106 | 1 (1) | 1,536 |
| 2021 | 6 | 161 | 0 | 1,713 |
| 2022 | 15 | 212 | 0 | 1,647 |
| 2023 | 10 | 136 | 0 | 2,068 |
| 2024 | 11 | 134 | 3 | 2,210 |
| 2025 | 10 | 177 | 0 | 2,178 |
| 2026 | 12 | 145 | 4 (1) | — |
What is it indicated for?
The Traxcess 0.014" Hydrophilic Guidewire is intended for general intravascular use, including the neuro and peripheral vasculature. The wire can be steered to facilitate the selective placement of diagnostic or therapeutic catheters. This device is not intended for use in coronary arteries.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K080863 · printed Nov 6, 2026
Cite this page
510(k) Report. “K080863: Traxcess 0.014 Hydrophilic Guidewire.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K080863
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026